The allele frequency of CYP2A6*4 in four ethnic groups of China

被引:6
|
作者
Pang, Cong [1 ]
Liu, Jin-Hui [1 ]
Xu, Yi-Song [1 ]
Chen, Chao [1 ]
Dai, Peng-Gao [1 ]
机构
[1] NW Univ Xian, Sch Life Sci, Natl Engn Res Ctr Miniaturized Detect Syst, Xian 710069, Peoples R China
基金
中国国家自然科学基金;
关键词
CYP2A6*4; Gene deletion; Allele frequency; Ethnic groups; CYP2A6 DELETION POLYMORPHISM; NICOTINE METABOLISM; GENE; CANCER; 5-FLUOROURACIL; VARIABILITY; POPULATIONS; ASSOCIATION; TEGAFUR; SMOKING;
D O I
10.1016/j.yexmp.2015.03.040
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The CYP2A6*4 allele, characterized as the whole deletion of this gene, is closely associated with nicotine dependence, cancer susceptibility, and drug responsiveness. The frequency of this molecular variant differs across populations. Although genetic polymorphisms of CYP2A6"4 and its functional results have been reported in Chinese Han population, the allele frequency of CYP2A6"4 was largely unknown in other Chinese ethnic population. In this study, we investigated the allele frequency of CYP2A6*4 in four main ethnic groups of China based on our newly developed quantitative real-time PCR assay. The frequencies of the CYP2A6*4 allele were 7.9%, 15%, 0% and 2% in Han (N = 120), Uighur (N = 100), Bouyei (N = 100) and Tibetan (N = 100) (P < 0.0001), respectively. This work greatly expanded our understanding of the distribution of CYP2A6*4 in Chinese population and provided more information of different ethnic population's smoking behavior and also in disease susceptibility and drug response. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:546 / 548
页数:3
相关论文
共 50 条
  • [1] Rapid detection of the CYP2A6*12 hybrid allele by Pyrosequencing® technology
    Koontz, Deborah A.
    Huckins, Jacqueline J.
    Spencer, Antonina
    Gallagher, Margaret L.
    BMC MEDICAL GENETICS, 2009, 10
  • [2] CYP2D6*4 null allele frequency in sixteen Pakistani ethnic groups
    Ullah, Anwar
    Riaz, Sana
    Siddiqi, Saima
    Mazhar, Kehkashan
    Mansoor, Atika
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 33 (02) : 739 - 743
  • [3] Functional Characterization of Cytochrome P450 2A6 Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22
    Tiong, Kai Hung
    Yiap, Beow Chin
    Tan, Eng Lai
    Ismail, Rusli
    Ong, Chin Eng
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) : 745 - 751
  • [4] Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method
    Mwenifumbo, JC
    Myers, MG
    Wall, TL
    Lin, SK
    Sellers, EM
    Tyndale, RF
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (03) : 189 - 192
  • [5] A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo
    Al Koudsi, Nael
    Ahluwalia, Jasjit S.
    Lin, Shih-Ku
    Sellers, Edward M.
    Tyndale, Rachel F.
    PHARMACOGENOMICS JOURNAL, 2009, 9 (04) : 274 - 282
  • [6] High prevalence of CYP2A6*4 and CYP2A6*9 alleles detected among a Malaysian population
    Yusof, Wardah
    Gan, Siew Hua
    CLINICA CHIMICA ACTA, 2009, 403 (1-2) : 105 - 109
  • [7] Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations
    Soriano, Antonia
    Vicente, Jorge
    Carcas, Cristina
    Gonzalez-Andrade, Fabricio
    Arenaz, Izaskun
    Martinez-Jarreta, Begona
    Fanlo, Ana
    Mayayo, Esteban
    Sinues, Blanca
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 (05) : 627 - 632
  • [8] A novel mutant allele of the CYP2A6 gene (CYP2A6*11) found in a cancer patient who showed poor metabolic phenotype towards tegafur
    Daigo, S
    Takahashi, Y
    Fujieda, M
    Ariyoshi, N
    Yamazaki, H
    Koizumi, W
    Tanabe, S
    Saigenji, K
    Nagayama, S
    Ikeda, K
    Nishioka, Y
    Kamataki, T
    PHARMACOGENETICS, 2002, 12 (04): : 299 - 306
  • [9] A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo
    Nael Al Koudsi
    Jasjit S Ahluwalia
    Shih-Ku Lin
    Edward M Sellers
    Rachel F Tyndale
    The Pharmacogenomics Journal, 2009, 9 : 274 - 282
  • [10] Characterization of the novel CYP2A6*21 allele using in vivo nicotine kinetics
    Nael Al Koudsi
    Jill C. Mwenifumbo
    Edward M. Sellers
    Neal L. Benowitz
    Gary E. Swan
    Rachel F. Tyndale
    European Journal of Clinical Pharmacology, 2006, 62 : 481 - 484